Search results for "Therapeutics"


 
Results 11 - 20 of about 400 for "Therapeutics".
Sort by: Relevance | Newest | Oldest

Chest physicians make 11 recommendations on antithrombotic therapy in COVID-19

The recommendations on prevention and management of arterial thrombosis and thromboembolism are not a major departure from prepandemic ones, according to an expert panel from the American College of Chest Physicians.
https://acphospitalist.acponline.org/archives/2023/07/05/free/chest-physicians-make-11-recommendations-on-antithrombotic-therapy-in-covid-19.htm
5 Jul 2023

Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19

Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
https://acphospitalist.acponline.org/archives/2023/03/29/free/higher-dose-prophylactic-anticoagulation-needed-to-prevent-thrombosis-in-hypoxemic-covid-19.htm
29 Mar 2023

Rapidly progressive cerebral edema in cryptococcal meningitis

A patient previously diagnosed with an upper respiratory infection presented with fever, headache, and confusion.
https://acphospitalist.acponline.org/archives/2023/03/29/free/rapidly-progressive-cerebral-edema-in-cryptococcal-meningitis.htm
29 Mar 2023

Over-the-counter test for flu, COVID-19 authorized

The FDA also approved albuterol and budesonide inhalation aerosol, the first combination of an inhaled corticosteroid and a short-acting beta-agonist for asthma, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/03/01/over-the-counter-test-for-flu-covid-19-authorized.htm
1 Mar 2023

Stopping the cycle of C. diff

Microbiota therapies offer exciting potential to reduce the burden of recurrent Clostridioides difficile infection, experts say.
https://acphospitalist.acponline.org/archives/2023/02/08/free/stopping-the-cycle-of-c-diff.htm
8 Feb 2023

New score developed to improve risk stratification in type 2 myocardial infarction

The T2-risk score incorporates age, ischemic heart disease, heart failure, diabetes, myocardial ischemia on electrocardiogram, heart rate, anemia, estimated glomerular filtration rate, and maximal cardiac troponin concentration.
https://acphospitalist.acponline.org/archives/2023/01/18/new-score-developed-to-improve-risk-stratification-in-type-2-myocardial-infarction.htm
18 Jan 2023

Hospitalists can help eliminate HCV

Hospitals are the latest frontier in global efforts to diagnose and treat hepatitis C virus (HCV).
https://acphospitalist.acponline.org/archives/2023/01/11/free/hospitalists-can-help-eliminate-hcv.htm
11 Jan 2023

AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure

Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://acphospitalist.acponline.org/archives/2022/12/14/aha-statement-reviews-efficacy-safety-of-cam-therapies-in-patients-with-heart-failure.htm
14 Dec 2022

An atypical presentation of microscopic polyangiitis

A patient was admitted after outpatient labs indicated acute worsening of kidney disease and anemia.
https://acphospitalist.acponline.org/archives/2022/10/26/free/brief-case-an-atypical-presentation-of-microscopic-polyangiitis.htm
26 Oct 2022

Hypothermic temperature control did not improve survival after in-hospital cardiac arrest

A randomized controlled trial in Germany that compared 24 hours of mild therapeutic hypothermia to normothermia in comatose resuscitated patients found no difference in survival to discharge or in all-cause survival and functional outcomes at 180 days.
https://acphospitalist.acponline.org/archives/2022/10/05/hypothermic-temperature-control-did-not-improve-survival-after-in-hospital-cardiac-arrest.htm
5 Oct 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next